Moderna
MRNA
#892
Rank
NZ$48.91 B
Marketcap
NZ$123.29
Share price
3.61%
Change (1 day)
172.24%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : NZ$7.21 Billion

According to Moderna 's latest financial reports the company's total liabilities are NZ$7.21 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Moderna - Total liabilities on balance sheet (from 2017 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$6.36 B10.81%
2024-12-31NZ$5.74 B-20.51%
2023-12-31NZ$7.22 B-31.85%
2022-12-31NZ$10.60 B-31.15%
2021-12-31NZ$15.40 B132.77%
2020-12-31NZ$6.61 B975.19%
2019-12-31NZ$0.61 B-4.39%
2018-12-31NZ$0.64 B-0.41%
2017-12-31NZ$0.64 B-22.15%
2016-12-31NZ$0.83 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
NZ$211.73 B 2,834.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$140.80 B 1,851.10%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$146.37 B 1,928.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
NZ$10.25 M-99.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
NZ$77.51 M-98.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$7.17 B-0.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ$2.95 B-59.08%๐Ÿ‡บ๐Ÿ‡ธ USA